SCHEMBL24328666

SCHEMBL24328666

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C(c3ccccc3)(c3ccc5c(ccc6ccccc65)c3)c3ccccc3-4)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
KMT2A Q03164 7/20 0.38
MEN1 O00255 6/20 0.38
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 3/20 0.38
OPRK1 P41145 1/20 0.38
NPC1 O15118 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 6/20 0.34
HPGD P15428 5/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ATM Q13315 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932674 0.95 MAPT (0.37) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL17932751 0.94 KMT2A (0.36) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL24328130 0.94 KMT2A (0.39) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL23759253 0.94 MAPT (0.36) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL24328693 0.93 MAPT (0.38) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL24306495 0.93 MAPT (0.42) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL26391783 0.92 PDK2 (0.37) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL23759289 0.92 MAPT (0.36) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL23759360 0.91 MAPT (0.36) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL24328634 0.90 MEN1 (0.42) MAPTKMT2AMEN1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299466-B2 Compound, and organic electronic element comprising same LG CHEM, LTD. 2022-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299466-B2 Compound, and organic electronic element comprising same OR10J3, ETV6, ODC1 MAPT 2593/4885KMT2A 639/4885MEN1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.